Review
Accepted on 02 Jul 2025
The effect of ubiquitination and deubiquitination to imatinib resistance in gastrointestinal stromal tumors
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1581920
Type at least 3 characters
3,053 articles
Systematic Review
Published on 02 Jul 2025
Lactylation and its roles in diseases: a systematic bibliometric exploration of the research landscape
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1569651
Review
Published on 01 Jul 2025
Targeting the nuclear orphan receptor NR4A1: a key target in lung cancer progression and therapeutic resistance
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1566598
- 385 views
Systematic Review
Published on 01 Jul 2025
Angiosarcoma: a systematic review of biomarkers in diagnosis, prognosis, and therapeutic strategies
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1623327
- 372 views
Correction
Accepted on 30 Jun 2025
Correction: Identification of hub genes within the CCL18 signaling pathway in hepatocellular carcinoma through bioinformatics analysis
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1649612
- 155 views
Original Research
Accepted on 30 Jun 2025
The construction and evaluation of a prognostic risk score model for HCC based on MPT-related LncRNAs
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1590094
Original Research
Accepted on 30 Jun 2025
A study on the clinical value of prophylactic contralateral central lymph node dissection in patients with cT1-T2N1b unilateral papillary thyroid cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1629656
Review
Accepted on 30 Jun 2025
YBX1: An RNA/DNA-binding protein that affects disease progression
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1635209
Original Research
Published on 30 Jun 2025
Prevalence of human papillomavirus genotypes in Latvia among women participating in cervical cancer screening
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1584677
- 342 views
Systematic Review
Published on 30 Jun 2025
Bibliometric analysis combined with visualization on universal trends and hot topics of LOX family in human diseases: 1995 to 2025
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1601261
- 235 views
Original Research
Accepted on 26 Jun 2025
To Explore the Potential of LOXL2 as a Biomarker in Glioma and Construct a Genomic Integrated Clinical Prognostic Model
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1602475
- 115 views
Review
Published on 26 Jun 2025
Decoding estrogen receptor and GPER biology: structural insights and therapeutic advances in ERα−positive breast cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1513225
- 313 views
Review
Published on 26 Jun 2025
The role of DNA methylation and demethylation in bladder cancer: a focus on therapeutic strategies
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1567242
- 338 views
Original Research
Accepted on 25 Jun 2025
Significance of FXa and its receptor PAR2 for the growth of colon cancer cells in vitro and in vivo
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1631350
Original Research
Published on 25 Jun 2025
Untargeted metabolomics revealed urinary metabolic pattern for discriminating prostate cancer from benign prostatic hyperplasia in Chinese participants
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1604169
- 419 views
Review
Published on 25 Jun 2025
Vaccine therapies for glioma: clinical frontiers and potential breakthrough
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1613332
- 439 views